Cibus CBUS
NASDAQ CBUS
$1.70 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cibus (CBUS) Depreciation & Amortization (CF) (2016 - 2026)

Cibus (CBUS) posted Depreciation & Amortization (CF) of $1.3 million for Q4 2025, down 8.87% sequentially from $1.4 million in Q3 2025, and down 21.48% YoY from $1.6 million in Q4 2024.

Cibus (CBUS) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends

Cibus has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $1.3 million in Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 21.48% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.9 million (down 13.65% YoY) and the FY2025 annual result came in at $5.9 million, down 13.65% from the prior year.
  • Depreciation & Amortization (CF) slipped to $1.3 million in Q4 2025 per CBUS's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.8 million in Q4 2023 and troughed at $370000.0 in Q1 2022.
  • A 5-year average of $1.1 million and a median of $999500.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) slumped 36.75% in 2022, then soared 383.51% in 2023.
  • Over 5 years, Depreciation & Amortization (CF) stood at $562000.0 in 2021, then slumped by 33.1% to $376000.0 in 2022, then jumped by 383.51% to $1.8 million in 2023, then slipped by 9.35% to $1.6 million in 2024, then dropped by 21.48% to $1.3 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1.3 million, $1.4 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 40.52 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 191.83 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cibus 129.72 Mn 109.29 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2026 681,000.00
Jun 30, 2026 681,000.00
Dec 31, 2025 1.29 Mn
Dec 31, 2025 1.29 Mn
Sep 30, 2025 1.42 Mn
Sep 30, 2025 1.42 Mn
Jun 30, 2025 1.58 Mn
Jun 30, 2025 1.58 Mn
Mar 31, 2025 1.63 Mn
Mar 31, 2025 1.63 Mn
Dec 31, 2024 1.65 Mn
Dec 31, 2024 1.65 Mn
Sep 30, 2024 1.66 Mn
Sep 30, 2024 1.66 Mn
Jun 30, 2024 1.76 Mn
Jun 30, 2024 1.76 Mn
Mar 31, 2024 1.79 Mn
Mar 31, 2024 1.79 Mn
Dec 31, 2023 1.82 Mn
Dec 31, 2023 1.82 Mn